• Is this ASX healthcare stock ready to rocket post-merger?

  • Feb 10 2025
  • Duración: 14 m
  • Podcast

Is this ASX healthcare stock ready to rocket post-merger?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Integral Diagnostics (ASX:IDX) had a great year in 2024; its share price was up around 50% as its business recovered from the post-Covid doldrums. It has just completed a merger with Capitol Health to make it Australia’s second largest radiology provider and IML portfolio manager Marc Whittaker believes this has it well set up for its next phase of growth.

    In this podcast Marc discusses why Integral Diagnostics is one of his highest conviction holdings in IML’s small and mid cap funds.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Is this ASX healthcare stock ready to rocket post-merger?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles